(EDSA) – Hot FDA News
-
Edesa Biotech (EDSA) Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study
-
Edesa Biotech (EDSA) Climbs 27% Pre Open After Favorable Mortality Reductions in COVID-19 Study
-
Back to EDSA Stock Lookup